Sec Form 4 Filing - ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp @ Apollo Medical Holdings, Inc. - 2023-11-14

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
2. Issuer Name and Ticker or Trading Symbol
Apollo Medical Holdings, Inc. [ AMEH]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
1668 S. GARFIELD AVE., 2ND FLOOR
3. Date of Earliest Transaction (MM/DD/YY)
11/14/2023
(Street)
ALHAMBRA, CA91801
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/14/2023 D( 2 ) 3,166,561 D $ 31.58 7,132,698 D ( 1 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
1668 S. GARFIELD AVE.
2ND FLOOR
ALHAMBRA, CA91801
X
Lam Thomas S.
1668 S. GARFIELD AVE.
2ND FLOOR
ALHAMBRA, CA91801
X Co-CEO and President
Sim Kenneth T.
1668 S. GARFIELD AVE.
2ND FLOOR
ALHAMBRA, CA91801
X Executive Chairman
Young Albert WaiChow
1668 S. GARFIELD AVE.
2ND FLOOR
ALHAMBRA, CA91801
Chief Administrative Officer
Signatures
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL CORPORATION, /s/ Thomas S. Lam, Chief Executive Officer and Chief Financial Officer 11/16/2023
Signature of Reporting Person Date
/s/ Thomas S. Lam 11/16/2023
Signature of Reporting Person Date
/s/ Kenneth T. Sim 11/16/2023
Signature of Reporting Person Date
/s/ Albert WaiChow Young 11/16/2023
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Allied Physicians of California, a Professional Medical Corporation ("APC") is a consolidated affiliate of the issuer of which Dr. Thomas Lam, the issuer's Co-Chief Executive Officer and President and a director, is the Chief Executive Officer and Chief Financial Officer and a director and stockholder; Dr. Kenneth Sim, the issuer's Executive Chairman, is Chairman and a director and stockholder; and Dr. Albert Young, the issuer's Chief Administrative Officer, is Senior Executive Vice President and a director and stockholder. Each of Dr. Lam, Dr. Sim and Dr. Young disclaims beneficial ownership of the securities held by APC except to the extent of his pecuniary interest therein. Each of Dr. Lam, Dr. Sim and Dr. Young holds, directly and/or indirectly, additional securities of the issuer.
( 2 )On November 6, 2023, the issuer entered into a stock repurchase agreement with APC, pursuant to which the issuer agreed to repurchase approximately $100 million of the issuer's common stock from APC. Pursuant to such agreement, on November 14, 2023, the issuer repurchased 3,166,561 shares of common stock from APC. The issuer's Board of Directors and the Audit Committee of the Board of Directors approved the repurchase.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.